Printed from acutecaretesting.org
January 2003
What to consider when performing method comparisons on blood gas analyzers
INTRODUCTION
The purpose of method comparison is to determine the agreement between two or more methods or analyzers measuring the same analyte.
The experiment is preferably performed on split samples measured on both methods, and any difference found between the two methods should be interpreted as analytical difference.
A method comparison is recommended whenever a new method or analyzer is introduced into a healthcare institution as part of a method validation. If two or more methods/analyzers are used simultaneously for the same analyte, these can, as a way to ensure equality, be compared regularly.
In the US, for instance, there is a legal requirement to perform method comparisons twice a year to validate this.
As the purpose is to determine if there is an analytical difference between the two methods, it is extremely important to eliminate inconsistent contributions from the preanalytical phase, which by experience is a major source of error during method validation of blood gas analyzers.
The objective of this article is, therefore, to provide checklists with the preanalytical and preparatory considerations when performing method comparisons on blood gas analyzers.
The typical parameters found on a blood gas analyzer are:
Blood gases and pH: pH, pO2, and
pCO2
Electrolytes: cNa+,
cK+, cCa2+, and
cCl-
Metabolites: ctBil, cLac, and
cGlu
Oximetry: ctHb, FCOHb,
FO2Hb, FMetHb, and
sO2
Preparatory considerations
When conducting a method comparison there are some preparatory issues that are important to address to ensure that the method comparison will reflect only the analytical differences between the two methods.
Checklist with general
preparatory
|
||
1. |
Expected outcome |
Prior to a method comparison it is necessary to determine the allowable difference (or bias if the comparative method is a reference method) on the analytes which is acceptable to the laboratory. |
Performance specifications |
In order to determine the allowable difference, it is necessary to take the known performance specifications of each of the two methods into account. Performance specifications such as inaccuracy and imprecision are often determined by the manufacturer and should include questionable results from calibration solutions, electrodes, etc. |
|
Matrix effect |
Analytical differences caused by a matrix effect [1] should be identified. An example is the measurement of electrolytes on direct or indirect ISE. |
|
Interfering substances |
It is also important to investigate whether the manufacturer has identified any interfering substances [2], which could influence the method performance. |
|
2. |
Test
|
The aim and the requirements of the study should be defined prior to starting the test. A detailed description of the test is needed for all participants. |
3. |
Thorough training |
All personnel participating in the test should be familiar with methodologies, maintenance, etc., on both methods prior to starting the test. |
4. |
Patient population |
The sample material should reflect the patient population from which the routine samples will come from. |
5. |
Range of results |
Within the given patient population it is important to have a sufficient range of results, representing also the extremes. If the samples are only used for method comparison, extended storage time is one way to gain values in the outer range. |
6. |
Sample material |
The sample material used for the test should reflect the material used for routine testing. It is preferable to analyze on split samples, if possible. If capillaries are used for neonatal testing, it is important that the samples are drawn at the same time and from the same site. |
7. |
Adequate sample volume |
Prior to the test, it is necessary to determine the volume of blood needed. |
8. |
Adequate number of samples |
It is debatable what the adequate number of samples is, and it may vary due to the nature of the analyte. The general recommendation by the NCCLS [3] is a minimum of 40 samples. |
9. |
Analyzer preparations |
Prior to the test, it is important to ensure that the analyzers are in control by doing QC and calibrations according to the manufacturers' recommendations. |
10. |
Storage of samples before measurements |
If the samples used for the method comparison are also used for patient evaluation, storage time before measurement should be according to the manufacturers' or the laboratory's procedures! |
11. |
Storage of samples between measurements |
As a blood sample is living material, storage between measuring on the two methods will change the values of most parameters and should, therefore, be minimized. |
TABLE I
Preanalytical considerations
The preanalytical issues listed in the table below
are the most important considerations when performing blood gas
analysis.
If the samples used for the method comparison are also used for patient evaluation, all of the listed preanalytical considerations are important and even more variables may be considered. However, if the results are only used for method comparison, some of the issues are less important, e.g. storage time before analysis.
By far the most important preanalytical consideration in connection with a method comparison is to ensure uniform quality of the sample that is introduced into the two methods.
For instance, minimizing storage time between the two measurements is critical. In order to avoid non-analytical errors, the best approach is to perform measurements on routine patient samples with the analyzers side by side.
Detailed description of
preanalytical
|
||
Blood gas and pH
|
||
1. |
Air
|
Air bubbles will have an effect on the pO2 results. Air bubbles must be removed prior to each measurement. |
2. |
Storage
|
Storage time1 between the measurements will affect pO2 and eventually pCO2 and pH. The maximum time between measurements on two methods should be 1-2 min. |
3. |
Storage temperature |
Storage temperature1 is less important when the sample is only used for a method comparison. |
Electrolytes
|
||
4. |
Hemolysis |
Hemolysis will affect cK+ and cCa2+. Avoid cooling a sample directly on ice or mixing it vigorously between measuring on the two methods. |
5. |
Storage
|
Storage time1 between the measurements can affect cK+ if the sample is stored cold for more than 30 min. The maximum time between measurements on the two methods should be 1-2 min. |
6. |
Evaporation |
Evaporation is another consequence of storage and can occur from open tubes or microcups. |
7. |
Anticoagulant |
It is important to ensure an even distribution of anticoagulant prior to the first analysis. |
8. |
Storage temperature |
Storage temperature1 is less important when the sample is only used for a method comparison. |
Metabolites
|
||
9. |
Storage time |
Avoiding storage time1 between measurements is one of the most essential considerations, especially for cGlu and cLac. The maximum time between measurements on the two methods should be 1-2 min. |
10. |
Evaporation |
Evaporation is another consequence of storage and can occur from open tubes or microcups. |
11. |
Hemolysis (Glu + Lac) |
Hemolysis affects cGlu and cLac on some enzymatic measuring methods and should be avoided [4]. Avoid cooling a sample directly on ice or mixing it vigorously between measuring on the two methods. |
12. |
Light |
Light degradation of bilirubin may affect the result [5]. |
Oximetry
|
||
13. |
Mixing |
Settled samples are the most common cause of errors on especially ctHb. Mixing the sample very thoroughly prior to the first measurement and between measurements is essential. |
14. |
Air
|
As air bubbles affect the pO2 result, the sO2 will also be affected. Air bubbles must be removed prior to each measurement |
15. |
Storage
|
The maximum storage time1 between measurements on the two methods should be 1-2 min. |
1 The recommended storage time for samples used for patient evaluation is max. 10 min. at room temperature and max. 30 min. at 0-4 oC (32-39 oF) [6]. The NCCLS recommedation is max. 3 min. at room temperature.
TABLE II
Other considerations
Below is a list of other considerations when performing method comparison.
According to NCCLS [3] it is recommended that you….
- Use at least 40 patient samples.
- Split the sample between the two analyzers.
- Alternate the sample sequence between the two methods.
- Perform the test over five operating days.
- Analyze each patient sample in duplicate on both methods.
- Whenever possible, 50 % of all samples should be outside the laboratory's reference interval. This will help validate patient samples outside normal reference values.
- After the comparison, NCCLS recommends that you analyze the
data for outliers and plot the data in a scatter plot and a
bias plot. The data analysis can be performed by using a
statistical tool, such as the EP evaluator. All documentation
from the method comparison needs to be saved for the regulatory
inspection and presented during the site inspection.
Other recommendations are to…. - Remember always to expel a few drops of blood from the blood gas syringe prior to the measurement and to wipe off the inlet to avoid contamination of the successive sample.
- When mixing, small air bubbles may develop. Be careful not to inject or aspirate them into the analyzer.
- If you are comparing an injection analyzer to an aspirating analyzer, use the injection analyzer first to avoid air bubbles contaminating the sample.
Conclusion
The objective of this article was to provide checklists with preparatory and preanalytical issues to be considered to ensure that a method comparison only reflects the analytical difference between two or more methods.References+ View more
- Lasky FD, Boone DJ, Eckfeldt JH et al. Evaluation of matrix effects. NCCLS Publication EP14-A. Wayne, Pa: NCCLS, 2001; 21,3.
- Powers DM, Boyd JC, Glick MR et al. Interference testing in clinical chemistry. NCCLS Publication EP7-P. Villanova, Pa.: NCCLS, 1986, 6,13.
- Krouwer JS, Tholen DW, Garber CC et al. Method comparison and bias estimation using patient samples. 2nd ed. NCCLS Publication EP9-A2. Wayne, Pa: NCCLS, 2002; 22,19.
- Young DS. Effects of preanalytical variables on clinical laboratory tests. 2nd edition. Washington: The American Association of Clinical Chemistry, Inc., 1997.
- Skurup A. Guide to evaluating bilirubin measurements - designing the optimal test. Radiometer Publication Bulletin no. 24-2001. Copenhagen: Radiometer Medical A/S, 2001.
- Lock R, Francke K, Nötzli B. The whole blood sampling handbook. Ed. 0005A. Copenhagen: Radiometer Medical A/S, 2000.
References
- Lasky FD, Boone DJ, Eckfeldt JH et al. Evaluation of matrix effects. NCCLS Publication EP14-A. Wayne, Pa: NCCLS, 2001; 21,3.
- Powers DM, Boyd JC, Glick MR et al. Interference testing in clinical chemistry. NCCLS Publication EP7-P. Villanova, Pa.: NCCLS, 1986, 6,13.
- Krouwer JS, Tholen DW, Garber CC et al. Method comparison and bias estimation using patient samples. 2nd ed. NCCLS Publication EP9-A2. Wayne, Pa: NCCLS, 2002; 22,19.
- Young DS. Effects of preanalytical variables on clinical laboratory tests. 2nd edition. Washington: The American Association of Clinical Chemistry, Inc., 1997.
- Skurup A. Guide to evaluating bilirubin measurements - designing the optimal test. Radiometer Publication Bulletin no. 24-2001. Copenhagen: Radiometer Medical A/S, 2001.
- Lock R, Francke K, Nötzli B. The whole blood sampling handbook. Ed. 0005A. Copenhagen: Radiometer Medical A/S, 2000.
Acute care testing handbook
Get the acute care testing handbook
Your practical guide to critical parameters in acute care testing.
Download nowRelated webinar
Evolution of blood gas testing Part 1
Presented by Ellis Jacobs, PhD, Assoc. Professor of Pathology, NYU School of Medicine.
Watch the webinar